AAAAAA
Results: 1-25/38
Authors:
Augarten, A
Akons, H
Aviram, M
Bentur, L
Blau, H
Picard, E
Rivlin, J
Miller, MS
Katznelson, D
Szeinberg, A
Shmilovich, H
Paret, G
Laufer, J
Yahav, Y
Citation: A. Augarten et al., Prediction of mortality and timing of referral for lung transplantation incystic fibrosis patients, PEDIAT TRAN, 5(5), 2001, pp. 339-342
Authors:
Keidar, S
Heinrich, R
Kaplan, M
Hayek, T
Aviram, M
Citation: S. Keidar et al., Angiotensin II administration to atherosclerotic mice increases macrophageuptake of oxidized LDL - A possible role for interleukin-6, ART THROM V, 21(9), 2001, pp. 1464-1469
Authors:
Kaplan, M
Aviram, M
Citation: M. Kaplan et M. Aviram, Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages - An alternative approach to study lipoproteins cellular uptake, ART THROM V, 21(3), 2001, pp. 386-393
Authors:
Wilson, SH
Simari, RD
Best, PJM
Peterson, TE
Lerman, LO
Aviram, M
Nath, KA
Holmes, DR
Lerman, A
Citation: Sh. Wilson et al., Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering, ART THROM V, 21(1), 2001, pp. 122-128
Authors:
Vaya, J
Aviram, M
Mahmood, S
Hayek, T
Grenadir, E
Hoffman, A
Milo, S
Citation: J. Vaya et al., Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins, FREE RAD RE, 34(5), 2001, pp. 485-497
Authors:
Fuhrman, B
Aviram, M
Citation: B. Fuhrman et M. Aviram, Flavonoids protect LDL from oxidation and attenuate atherosclerosis, CURR OP LIP, 12(1), 2001, pp. 41-48
Authors:
Guttmann, H
Weiner, Z
Nikolski, E
Ish-Shalom, S
Itskovitz-Eldor, J
Aviram, M
Reisner, S
Hochberg, Z
Citation: H. Guttmann et al., Choosing an oestrogen replacement therapy in young adult women with Turnersyndrome, CLIN ENDOCR, 54(2), 2001, pp. 159-164
Authors:
Aviram, M
Vaya, J
Citation: M. Aviram et J. Vaya, Markers for low-density lipoprotein oxidation, METH ENZYM, 335, 2001, pp. 244-256
Authors:
Kaplan, M
Hayek, T
Raz, A
Coleman, R
Dornfeld, L
Vaya, J
Aviram, M
Citation: M. Kaplan et al., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis, J NUTR, 131(8), 2001, pp. 2082-2089
Authors:
Aviram, M
Dornfeld, L
Citation: M. Aviram et L. Dornfeld, Pomegranate juice consumption inhibits serum angiotensin converting enzymeactivity and reduces systolic blood pressure, ATHEROSCLER, 158(1), 2001, pp. 195-198
Authors:
Fuhrman, B
Volkova, N
Suraski, A
Aviram, M
Citation: B. Fuhrman et al., White wine with red wine-like properties: Increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine, J AGR FOOD, 49(7), 2001, pp. 3164-3168
Authors:
Augarten, A
Shmilovich, H
Doolman, R
Aviram, M
Akons, H
Ben Tur, L
Blau, H
Kerem, E
Rivlin, J
Sela, BA
Szeinberg, A
Yahav, Y
Citation: A. Augarten et al., Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests, PEDIAT PULM, 30(4), 2000, pp. 320-323
Authors:
Aviram, M
Citation: M. Aviram, Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases, FREE RAD RE, 33, 2000, pp. S85-S97
Authors:
Levy, Y
Zaltsberg, H
Ben-Amotz, A
Kanter, Y
Aviram, M
Citation: Y. Levy et al., Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus, ANN NUTR M, 44(2), 2000, pp. 54-60
Authors:
Fuhrman, B
Rosenblat, M
Hayek, T
Coleman, R
Aviram, M
Citation: B. Fuhrman et al., Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice, J NUTR, 130(5), 2000, pp. 1124-1131
Authors:
Maor, I
Hayek, T
Hirsh, M
Iancu, TC
Aviram, M
Citation: I. Maor et al., Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice, ATHEROSCLER, 150(1), 2000, pp. 91-101
Authors:
Kaplan, M
Aviram, M
Citation: M. Kaplan et M. Aviram, Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidizedlow-density lipoprotein, ATHEROSCLER, 149(1), 2000, pp. 5-17
Authors:
Aviram, M
Hardak, E
Vaya, J
Mahmood, S
Milo, S
Hoffman, A
Billicke, S
Draganov, D
Rosenblat, M
Citation: M. Aviram et al., Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities, CIRCULATION, 101(21), 2000, pp. 2510-2517
Authors:
Hayek, T
Aviram, M
Heinrich, R
Sakhnini, E
Keidar, S
Citation: T. Hayek et al., Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients, BIOC BIOP R, 273(2), 2000, pp. 417-420
Authors:
Vuletich, JL
Osawa, Y
Aviram, M
Citation: Jl. Vuletich et al., Enhanced lipid oxidation by oxidatively modified myoglobin: Role of protein-bound heme, BIOC BIOP R, 269(3), 2000, pp. 647-651
Authors:
Maor, I
Kaplan, M
Hayek, T
Vaya, J
Hoffman, A
Aviram, M
Citation: I. Maor et al., Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols, BIOC BIOP R, 269(3), 2000, pp. 775-780
Authors:
Aviram, M
Dornfeld, L
Rosenblat, M
Volkova, N
Kaplan, M
Colemann, R
Hayek, T
Presser, D
Fuhrman, B
Citation: M. Aviram et al., Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice, AM J CLIN N, 71(5), 2000, pp. 1062-1076
Authors:
Zaltzberg, H
Kanter, Y
Aviram, M
Levy, Y
Citation: H. Zaltzberg et al., Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM, ISR MED ASS, 1(4), 1999, pp. 228-231
Authors:
Kaplan, M
Aviram, M
Citation: M. Kaplan et M. Aviram, Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase, CLIN CH L M, 37(8), 1999, pp. 777-787
Authors:
Aviram, M
Citation: M. Aviram, Does paraoxonase play a role in susceptibility to cardiovascular disease?, MOL MED TOD, 5(9), 1999, pp. 381-386